150
Participants
Start Date
August 28, 2013
Primary Completion Date
March 14, 2016
Study Completion Date
December 31, 2025
LY2875358
Administered IV
Erlotinib
Administered Orally
Rigshospitalet, Copenhagen
Herlev and Gentofte Hospital, Herlev
Odense Universitetshospital, Odense C
National Taiwan University Hospital, Taipei
Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano
Taipei Veterans General Hospital, Taipei
Seoul National University Bundang Hospital, Seongnam
CHU de Caen Hopital Cote de Nacre, Caen
Helios Klinikum Emil von Behring Berlin-Zehlendorf, Berlin
Gachon University Gil Medical Center, Namdong-gu
Universitätsklinikum Schleswig-Holstein, Lübeck
Istituti Ospedalieri di Cremona, Cremona
Hospital Puerta De Hierro, Majadahonda
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Chungbuk National University Hospital, Cheongju-si
Clinica Universitaria De Navarra, Pamplona
Hôpital Arnaud de Villeneuve - CHU Montpellier, Montpellier
Istituto Oncologico Veneto IRCCS, Padua
CHU De Grenoble Hopital Albert Michallon, Grenoble
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
Ulsan University Hospital, Ulsan
Azienda Ospedaliera Universitaria Careggi, Florence
Klinikum Köln-Merheim, Cologne
Chu Gabriel Montpied, Clermont-Ferrand
Thoraxklinik-Heidelberg gGmbH, Heidelberg
HCL-Hôpital Louis Pradel, Lyon (Bron) Cedex
"Istituto Tumori Giovanni Paolo II", Bari
Klinik Schillerhöhe, Gerlingen
CHU la Miletrie, Poitiers
Universitätsklinikum Ulm, Ulm
Jeroen Bosch Hospital, 's-Hertogenbosch
Ziekenhuis Rijnstate, Arnhem
Ziekenhuis St. Jansdal, Harderwijk
St. Antonius Ziekenhuis, locatie Nieuwegein, Nieuwegein
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Corporacion Sanitaria Parc Tauli, Sabadell
Hospital del Mar, Barcelona
Gartnavel General Hospital, Glasgow
Charing Cross Hospital, Chelsea
Wythenshawe Hospital, Wythenshawe
New Cross Hospital, Wolverhampton
Churchill Hospital, Oxford
Eli Lilly and Company
INDUSTRY